Navigation Links
synthesis - What's the Real Objective - Outcomes!
Date:9/11/2009

SEATTLE, Sept. 11 /PRNewswire/ -- The following blog post was published September 4, 2009, by Shafeen Charania, author of the synthesis blog, winner of the 2008 Weblog award for best new blog, and Time.com's 25 best blogs of 2009.

It's true that the devil is in the details, but if you get so focused on the details that you forget about the outcome you're trying to create, then whatever you're doing, however well the "process" worked, and however well your meetings went, you are at risk of failure.

Today healthcare is at the forefront of the American politic - but even here, the real goals are not addressed. It's not about a public option or tort reform or even budgets. The real goal has to be a healthier nation - period. None of these small issues matter if you forget about the big one! For example - the current system is more successful when more people are sick!? How does that motivate the right outcomes??

There are better approaches - to learn more, please visit: http://interacc.typepad.com/synthesis/2009/09/outcomes.htmlhttp://interacc.typepad.com/synthesis/2009/05/sorry-seems-to-be-the-hardest-word.html.

Thank you


'/>"/>
SOURCE synthesis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Trans Ionics Announces New Service - Custom Separation Synthesis (CSS)(TM)
2. Digital mammography plus digital breast tomosynthesis may decrease patient recall rates
3. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
4. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
5. Microwave synthesis connects with the (quantum) dots
6. Thomson Reuters Adds Routes of Synthesis Data to Its Newport Horizon Premium and Newport Vision Premium Solutions
7. Synthesis of natural molecule could lead to better anti-cancer drugs
8. National Healthcare Providers Select onFocus epm(TM) To Help Ensure Success on Financial and Strategic Objectives
9. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
10. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
11. Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... 24, 2016 , ... The number of health insurance policies ... over last year, according to data in the forthcoming AIS’s Directory of Health ... with a slight decrease in risk-based groups and a slight increase in administrative-services-only/self-funded ...
(Date:5/24/2016)... ... May 24, 2016 , ... Bio-Logic Aqua® Research Water Life ... and a trainer for Ageless Grace ( http://www.agelessgrace.com ) to discuss healthier lifestyles, ... 16, 2016. , Formerly a Northwestern University Literature Professor, Kinst gravitated to her ...
(Date:5/24/2016)... ... ... WaterAid launched the #perioddrama campaign to mark Menstrual Hygiene Day on May 28 and ... who do not have access to a toilet, even when they’re on their periods. , ... The (sometimes hilarious) results help shine a light on the awkwardness that women face while ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent ... of the potential of contaminated well water throughout the Houston area. , Heavy floodwaters ... well water that’s exposed to contaminants. Residents may not even be aware of the ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... today announced a licensing relationship that will deliver a new series of Q&A ... will put the medical knowledge and expertise of Harvard Medical School faculty into ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met ... and superiority in , Excellent plus ... of the ascending colon   , ... B.V. today announced new positive data from the phase III MORA ... standard 2 litre PEG with ascorbate. The study met both primary ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
(Date:5/24/2016)... KONG , May 24, 2016 /PRNewswire/ ... COMBO ™ , la première ... des cathéters destinés à l,intervention portant sur ... (FAV)   OrbusNeich, entreprise mondiale ... permettant de changer la vie, a élargi ...
Breaking Medicine Technology: